Herbst Group LLC Buys New Shares in GE HealthCare Technologies Inc. $GEHC

Herbst Group LLC purchased a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 27,750 shares of the company’s stock, valued at approximately $2,276,000.

A number of other hedge funds have also recently bought and sold shares of GEHC. Wedge Capital Management L L P NC bought a new position in shares of GE HealthCare Technologies in the third quarter valued at $26,859,000. Temasek Holdings Private Ltd bought a new stake in GE HealthCare Technologies during the third quarter worth $99,922,000. Valicenti Advisory Services Inc. raised its position in GE HealthCare Technologies by 22.6% during the third quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock worth $5,115,000 after acquiring an additional 12,550 shares in the last quarter. Locust Wood Capital Advisers LLC lifted its stake in GE HealthCare Technologies by 7.1% in the third quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock valued at $156,534,000 after acquiring an additional 137,992 shares during the last quarter. Finally, Nan Fung Trinity HK Ltd. acquired a new stake in GE HealthCare Technologies in the third quarter valued at $23,206,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $71.98 on Thursday. The company has a market cap of $32.84 billion, a P/E ratio of 15.79, a P/E/G ratio of 1.57 and a beta of 1.17. The firm’s fifty day moving average price is $77.31 and its two-hundred day moving average price is $78.13. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $89.77. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The company had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. GE HealthCare Technologies’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the company posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a dividend of $0.035 per share. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Barclays raised their target price on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a research note on Friday, February 6th. Jefferies Financial Group lifted their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Bank of America boosted their price target on GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a research report on Monday, January 5th. Finally, Morgan Stanley upped their price objective on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 4th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, GE HealthCare Technologies currently has an average rating of “Hold” and an average target price of $92.17.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.